These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 27248460)

  • 21. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry.
    Barge-Caballero E; Almenar-Bonet L; Gonzalez-Vilchez F; Lambert-Rodríguez JL; González-Costello J; Segovia-Cubero J; Castel-Lavilla MA; Delgado-Jiménez J; Garrido-Bravo IP; Rangel-Sousa D; Martínez-Sellés M; De la Fuente-Galan L; Rábago-Juan-Aracil G; Sanz-Julve M; Hervás-Sotomayor D; Mirabet-Pérez S; Muñiz J; Crespo-Leiro MG
    Eur J Heart Fail; 2018 Jan; 20(1):178-186. PubMed ID: 28949079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.
    Droogne W; Jacobs S; Van den Bossche K; Verhoeven J; Bostic RR; Vanhaecke J; Van Cleemput J; Rega F; Meyns B
    Acta Clin Belg; 2014 Jun; 69(3):165-70. PubMed ID: 24820923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing Adaptive Changes and Patient Survival After 2018 Donor Allocation Restructuring: A UNOS Database Analysis.
    Miyamoto T; Pritting CD; Tatum R; Ahmad D; Brailovsky Y; Shah MK; Rajapreyar I; Rame JE; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Crit Pathw Cardiol; 2024 Jun; 23(2):81-88. PubMed ID: 38768050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK.
    Borisenko O; Wylie G; Payne J; Bjessmo S; Smith J; Firmin R; Yonan N
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):41-8. PubMed ID: 24667583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in long-term mechanical circulatory support for advanced heart failure in the UK.
    Emin A; Rogers CA; Parameshwar J; Macgowan G; Taylor R; Yonan N; Simon A; Tsui S; Schueler S; Banner NR; ; UK VAD Forum
    Eur J Heart Fail; 2013 Oct; 15(10):1185-93. PubMed ID: 23901056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support.
    Kurihara C; Kawabori M; Sugiura T; Critsinelis AC; Wang S; Cohn WE; Civitello AB; Frazier OH; Morgan JA
    Artif Organs; 2018 Jun; 42(6):589-596. PubMed ID: 29473181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcome After Venoarterial Extracorporeal Membrane Oxygenation as Bridge to Left Ventricular Assist Device Preceding Heart Transplantation.
    Coeckelenbergh S; Valente F; Mortier J; Engelman E; Roussoulières A; El Oumeiri B; Antoine M; Van Obbergh L; Taccone FS; Vanden Eynden F; Stefanidis C
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1694-1702. PubMed ID: 34330577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.
    Pagani FD; Lynch W; Swaniker F; Dyke DB; Bartlett R; Koelling T; Moscucci M; Deeb GM; Bolling S; Monaghan H; Aaronson KD
    Circulation; 1999 Nov; 100(19 Suppl):II206-10. PubMed ID: 10567305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation.
    Emin A; Rogers CA; Banner NR;
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):269-73. PubMed ID: 27107045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.
    Vitali E; Lanfranconi M; Bruschi G; Russo C; Colombo T; Ribera E
    J Card Surg; 2003; 18(2):107-13. PubMed ID: 12757336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.